Avoro Capital Advisors LLC 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:31 am Purchase | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | Avoro Capital Advisors LLC | 4,988,888 8.200% | 1,233,333 (+32.84%) | Filing |
| 2024-02-14 09:17 am Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | Avoro Capital Advisors LLC | 3,755,555 6.500% | 655,555 (+21.15%) | Filing |
| 2023-02-14 09:33 am Purchase | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | Avoro Capital Advisors LLC | 3,100,000 5.400% | 3,100,000 (New Position) | Filing |